- Q1 2024 2Seventy Bio Inc Earnings Call TranscriptMay 08, 2024$4.48 (-9.68%)Earnings
- Q4 2023 2Seventy Bio Inc Earnings Call TranscriptMar 05, 2024$5.79 (+6.83%)Earnings
- 2Seventy Bio Inc Investor Call TranscriptDec 12, 2023
- Q3 2023 2Seventy Bio Inc Earnings Call TranscriptNov 14, 2023$2.28 (+0.88%)Earnings
- 2Seventy Bio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- 2Seventy Bio Inc Conference Call TranscriptSep 12, 2023
- Q2 2023 2Seventy Bio Inc Earnings Call TranscriptAug 14, 2023$6.03 (+1.34%)Earnings
- 2seventy bio, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 03:20 PM TranscriptJun 14, 2023
- 2Seventy Bio Inc R&D Deep Dive Presentation (Virtual) TranscriptMay 19, 2023
- Q1 2023 2Seventy Bio Inc Earnings Call TranscriptMay 03, 2023$10.05 (-1.28%)Earnings
- Atara Biotherapeutics Inc, Cellectis SA and 2Seventy Bio Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 2Seventy Bio Inc Earnings Call TranscriptAug 10, 2022$17.22 (+3.11%)Earnings
- 2Seventy Bio Inc Focus on bNHL and Solid Tumor Strategy Conference Call TranscriptSep 22, 2021
- 2Seventy Bio Inc Introduction to 2seventy's Pipeline and Next-Gen Multiple Myeloma Strategy Conference Call TranscriptSep 21, 2021
Q2 2022 2Seventy Bio Inc Earnings Call Transcript
Hello and welcome to 2seventy bio's second-quarter 2022 financial results conference call. (Operator Instructions). Please be advised that this call is being recorded. I would now like to turn the call over to Jenn Snyder, head of corporate affairs. You may begin.
Thank you, operator. This morning 2seventy bio issued a press release providing a business update in addition to second-quarter 2022 financial results. The press release can be found in the Investors & Media section of the company's website at 2seventybio.com. On the call today are Nick Leschly, Chief Kairos Officer; Chip Baird, Chief Financial Officer; and Steve Bernstein, Chief Medical Officer.
As a reminder, today's discussion will include forward-looking statements related to 2seventy bio's current plans and expectations which are subject to certain risks and uncertainties. These forward-looking statements include statements regarding our strategic plans, timelines and expectations and statements regarding our financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)